Zhili Xin
Metabolic Disease Research
Global Pharmaceutical Research and Development
Abbott Laboratories
Abbott Park
USA
Name/email consistency: high
- Discovery and pharmacological evaluation of growth hormone secretagogue receptor antagonists. Xin, Z., Serby, M.D., Zhao, H., Kosogof, C., Szczepankiewicz, B.G., Liu, M., Liu, B., Hutchins, C.W., Sarris, K.A., Hoff, E.D., Falls, H.D., Lin, C.W., Ogiela, C.A., Collins, C.A., Brune, M.E., Bush, E.N., Droz, B.A., Fey, T.A., Knourek-Segel, V.E., Shapiro, R., Jacobson, P.B., Beno, D.W., Turner, T.M., Sham, H.L., Liu, G. J. Med. Chem. (2006)
- Synthesis and structure-activity relationships of isoxazole carboxamides as growth hormone secretagogue receptor antagonists. Xin, Z., Zhao, H., Serby, M.D., Liu, B., Schaefer, V.G., Falls, D.H., Kaszubska, W., Colins, C.A., Sham, H.L., Liu, G. Bioorg. Med. Chem. Lett. (2005)
- Identification of a monoacid-based, cell permeable, selective inhibitor of protein tyrosine phosphatase 1B. Xin, Z., Liu, G., Abad-Zapatero, C., Pei, Z., Szczepankiewicz, B.G., Li, X., Zhang, T., Hutchins, C.W., Hajduk, P.J., Ballaron, S.J., Stashko, M.A., Lubben, T.H., Trevillyan, J.M., Jirousek, M.R. Bioorg. Med. Chem. Lett. (2003)
